Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-03 4:41 pm Purchase |
2021-12-31 | 13G | Revance Therapeutics, Inc. RVNC |
BlackRock Inc. BLK |
5,334,099 7.400% |
321,747 (+6.42%) |
Filing History |
| 2022-01-18 12:59 pm Purchase |
2021-12-31 | 13G | Revance Therapeutics, Inc. RVNC |
JPMORGAN CHASE & CO JPM |
6,794,223 9.400% |
2,727,181 (+67.06%) |
Filing History |
| 2021-02-16 1:29 pm Sale |
2020-12-31 | 13G | Revance Therapeutics, Inc. RVNC |
ArrowMark Colorado Holdings LLC | 2,964,135 4.500% |
-1,876,501 (-38.77%) |
Filing History |
| 2021-02-12 4:32 pm Purchase |
2020-12-31 | 13G | Revance Therapeutics, Inc. RVNC |
GIC Private Ltd | 3,830,951 5.760% |
865,400 (+29.18%) |
Filing History |
| 2021-02-10 06:01 am Sale |
2021-01-20 | 13G | Revance Therapeutics, Inc. RVNC |
Essex Woodlands Health Ventures VIII L.L.C. | 457,085 0.007% |
-2,884,962 (-86.32%) |
Filing History |
| 2021-02-05 07:51 am Purchase |
2020-12-31 | 13G | Revance Therapeutics, Inc. RVNC |
BlackRock Inc. BLK |
5,012,352 7.500% |
1,323,695 (+35.89%) |
Filing History |
| 2021-02-04 11:42 am Sale |
2020-12-31 | 13G | Revance Therapeutics, Inc. RVNC |
Wellington Management Group LLP | 3,397,872 5.110% |
-345,828 (-9.24%) |
Filing History |
| 2021-02-02 2:44 pm Sale |
2020-12-31 | 13G | Revance Therapeutics, Inc. RVNC |
FRANKLIN RESOURCES INC BEN |
1,755,863 2.600% |
-1,827,109 (-50.99%) |
Filing History |
| 2021-01-29 09:25 am Purchase |
2020-12-31 | 13G | Revance Therapeutics, Inc. RVNC |
JPMORGAN CHASE & CO JPM |
4,067,042 6.100% |
38,545 (+0.96%) |
Filing History |
| 2020-08-10 09:43 am Sale |
2020-07-31 | 13G | Revance Therapeutics, Inc. RVNC |
Wellington Management Group LLP | 3,743,700 5.680% |
-2,044,345 (-35.32%) |
Filing History |